1. Which of the following characteristics is true for the Food and Drug Administration (FDA)-approved cannabidiol product (Epidiolex) that is not true for over-the-counter (OTC) cannabidiol (CBD) products?

2. Which of the following safety concerns is the most important to address when counseling patients about the use of over-the-counter (OTC) cannabidiol (CBD)?

3. Which of the following is true about the 2018 Farm Bill?

« Return to Activity